N-Acetyl Selank Amidate vs P21 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
N-Acetyl Selank Amidate is a doubly-modified form of Selank (a synthetic heptapeptide based on tuftsin) with N-acetylation at the N-terminus and amidation at the C-terminus. These modifications extend enzymatic stability and CNS bioavailability, making it the highest-potency form...
Calculate N-Acetyl Selank Amidate dose →P21 is a synthetic peptide derived from ciliary neurotrophic factor (CNTF), designed to promote neurogenesis - the formation of new neurons - in the hippocampus and olfactory bulb. CNTF is a potent neurotrophic factor but has poor CNS penetration and causes significant systemic s...
Calculate P21 dose →| Parameter | N-Acetyl Selank Amidate | P21 |
|---|---|---|
| Category | Cognitive & Neurological | Cognitive & Neurological |
| Research | Research Use | Preclinical |
| Half-Life | ~6–8 hours (estimated; extended vs. standard Selank) | - |
| Typical Dose | 100–300 µg | 100 µg/day |
| Frequency | Once or twice daily | Daily |
| Route | Intranasal | Subcutaneous / Intranasal |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.